Article
EZH2 coordinates inflammatory and pain-associated pathways across joint compartments in osteoarthritis
2025-01-22
Abstract excerpt
Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase responsible for H3K27 trimethylation, has emerged as a potential therapeutic target in osteoarthritis (OA). However, its contribution to the multicellular mechanisms driving joint degeneration and pain remains poorly understood. Here, we investigated the effects of pharmacological EZH2 inhibition in a pain-relevant murine OA model and explored its cel...
Topics
Open a Topic to create a Post that cites this publication.
- Autoimmune and Inflammatory Disorders Research
- Cancer-related molecular mechanisms research
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
- Inflammatory mediators and NSAID effects
- Osteoarthritis Treatment and Mechanisms
Identifiers and source
- Literature Corpus work
- f7974790-22d3-5381-9203-933cfa8e6a9a
- DOI
- 10.1101/2025.01.19.633762
